Dr. Mili Shah, MD
NPI: 1780038513
Total Payments
$1,760
2024 Payments
$485.25
Companies
16
Transactions
72
Medicare Patients
1,102
Medicare Billing
$135,855
Payment Breakdown by Category
Food & Beverage$1,760 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,760 | 72 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $692.03 | 16 | $0 (2024) |
| Novo Nordisk Inc | $262.89 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $109.21 | 5 | $0 (2023) |
| Shionogi Inc | $80.32 | 3 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $79.03 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $76.60 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $75.25 | 4 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $62.76 | 4 | $0 (2022) |
| Merck Sharp & Dohme LLC | $62.49 | 3 | $0 (2022) |
| PFIZER INC. | $55.76 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $485.25 | 26 | Novo Nordisk Inc ($183.07) |
| 2023 | $207.41 | 11 | Novo Nordisk Inc ($79.82) |
| 2022 | $900.85 | 27 | Janssen Pharmaceuticals, Inc ($510.54) |
| 2021 | $98.87 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($46.12) |
| 2020 | $67.12 | 3 | Janssen Pharmaceuticals, Inc ($33.05) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/15/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $25.18 | General |
| Category: Cardiovascular | ||||||
| 07/08/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/06/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/23/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, ZINPLAVA | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/08/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/23/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, ZINPLAVA | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/10/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/04/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: RESPIRATORY | ||||||
| 04/26/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/06/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/05/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.63 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/02/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), RELISTOR | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Gastroenterology | ||||||
| 02/07/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: DIABETES | ||||||
| 01/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/25/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Cardiovascular & Me | ||||||
| 12/15/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Gastroenterology | ||||||
| 11/10/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Gastroenterology | ||||||
| 04/14/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: DIABETES | ||||||
| 01/25/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: DIABETES | ||||||
| 10/30/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $33.05 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/28/2020 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/21/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 391 | 497 | $77,452 | $35,204 |
| 2022 | 4 | 269 | 467 | $90,017 | $37,334 |
| 2021 | 4 | 258 | 390 | $65,160 | $33,306 |
| 2020 | 5 | 184 | 285 | $77,840 | $30,011 |
Total Patients
1,102
Total Services
1,639
Medicare Billing
$135,855
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 179 | $42,641 | $16,729 | 39.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 76 | 76 | $12,160 | $9,764 | 80.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 32 | $5,390 | $2,148 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,572 | $1,874 | 33.6% |
| 77067 | Screening mammography | Office | 2023 | 11 | 11 | $5,034 | $1,425 | 28.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 102 | 137 | $2,329 | $1,144 | 49.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 15 | $1,800 | $1,079 | 59.9% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 11 | 11 | $2,058 | $582.56 | 28.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $468.00 | $458.64 | 98.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 150 | 315 | $57,615 | $25,249 | 43.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 64 | 64 | $14,563 | $5,125 | 35.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 34 | 67 | $9,200 | $3,715 | 40.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $8,640 | $3,245 | 37.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 128 | 230 | $36,800 | $19,552 | 53.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 49 | 79 | $9,085 | $4,718 | 51.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 29 | 29 | $9,135 | $4,584 | 50.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 52 | 52 | $10,140 | $4,452 | 43.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 74 | 168 | $28,042 | $14,383 | 51.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 63 | 64 | $34,182 | $10,481 | 30.7% |
| 99220 | Hospital observation care, typically 70 minutes | Office | 2020 | 16 | 16 | $9,648 | $2,370 | 24.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 20 | 20 | $3,900 | $1,773 | 45.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 11 | 17 | $2,068 | $1,004 | 48.5% |
About Dr. Mili Shah, MD
Dr. Mili Shah, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2016. The National Provider Identifier (NPI) number assigned to this provider is 1780038513.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mili Shah, MD has received a total of $1,760 in payments from pharmaceutical and medical device companies, with $485.25 received in 2024. These payments were reported across 72 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,760).
As a Medicare-enrolled provider, Shah has provided services to 1,102 Medicare beneficiaries, totaling 1,639 services with total Medicare billing of $135,855. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Syracuse, NY
- Active Since 04/18/2016
- Last Updated 03/13/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780038513
Products in Payments
- XARELTO (Drug) $567.97
- Ozempic (Drug) $137.85
- SPRAVATO (Drug) $124.06
- ELIQUIS (Drug) $101.59
- Fetroja (Drug) $80.32
- TZIELD (Biological) $76.60
- Rybelsus (Drug) $75.10
- LOKELMA (Drug) $65.71
- JARDIANCE (Drug) $62.95
- DIFICID (Drug) $62.49
- Kcentra (Biological) $49.49
- QUVIVIQ (Drug) $46.66
- Cologuard Collection Kit (Device) $46.15
- RELISTOR (Drug) $46.05
- Wegovy (Drug) $28.73
- CAMZYOS (Drug) $24.01
- PREVNAR 20 (Biological) $23.11
- GEMTESA (Drug) $23.08
- Saxenda (Drug) $21.21
- VRAYLAR (Drug) $20.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Syracuse
Seokhyun Jin, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $24,625
Student in an Organized Health Care Education/Training Program $24,625
Dr. Avneet Singh, M.b.b.s, M.B.B.S
Student in an Organized Health Care Education/Training Program — Payments: $16,015
Student in an Organized Health Care Education/Training Program $16,015
Dr. Rebecca Jameson, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,760
Student in an Organized Health Care Education/Training Program $4,760
Nelson Sofoluke, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $4,288
Student in an Organized Health Care Education/Training Program $4,288
Dr. Tarek Ibrahim, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,187
Student in an Organized Health Care Education/Training Program $3,187
Dr. David Padalino, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $3,144
Student in an Organized Health Care Education/Training Program $3,144